Fundraising Fox
Title21 Health Solutions
Founded 2001 · 35 employees on LinkedIn · 1 known investors
Find your way into Title21 Health Solutions
Sign up to see every warm intro you have to Title21 Health Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Title21 Health Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Title21 provides software solutions for cellular therapy and biopharmaceutical manufacturing organizations, offering digital tools for patient coordination, manufacturing workflows, quality management, and regulatory compliance.
Founders & leadership
TP
Tony PareChief Executive Officer2024–2026Tony Pare held executive roles in healthcare, including Chief Commercial Officer at T2 Biosystems where he led a pivot to SARS-CoV-2 diagnostics, and a position at BioPorto, a publicly traded diagnostics company, where he managed FDA approval for a biomarker assay for acute kidney injury risk assessment. His background spans medical devices, in vitro diagnostics, and healthcare software, with experience in strategic planning, fundraising, and organizational leadership.
Investors · 1
Frequently asked questions
- What does Title21 Health Solutions do?
- Title21 provides software solutions for cellular therapy and biopharmaceutical manufacturing organizations, offering digital tools for patient coordination, manufacturing workflows, quality management, and regulatory compliance.
- Who are Title21 Health Solutions's investors?
- Title21 Health Solutions's investors include ARCHIMED Japan.